Dermata Therapeutics Proposes $15 Million IPO
Obencem/iStock via Getty Images
Quick Take
Dermata Therapeutics (DRMA) has filed to raise $15 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing treatments for medical…
